Status:
ACTIVE_NOT_RECRUITING
Prevalence of OSA and Diagnostic Accuracy of Type 3 Home Sleep Test in Difficult-to-treat Asthma
Lead Sponsor:
Chulalongkorn University
Conditions:
OSA
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
cross sectional cohort study enroll Patients diagnosed with difficult-to-treat asthma, aged over 18 years, and experiencing persistent symptoms as assessed by the Asthma Control Test (ACT) underwent t...
Eligibility Criteria
Inclusion
- difficult-to-treat asthma .
- Patients aged 18 years or older
Exclusion
- Patients or volunteers unable to undergo type 1 and type 3 sleep studies,
- Patients with symptoms compatible with other sleep disorders,
- Patients with a history of or current stroke or transient ischemic attack and Other chronic respiratory diseases.
- Patients diagnosed with obstructive sleep apnea
Key Trial Info
Start Date :
February 7 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2025
Estimated Enrollment :
37 Patients enrolled
Trial Details
Trial ID
NCT06916858
Start Date
February 7 2024
End Date
June 30 2025
Last Update
June 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tidarat Somreusean
Bangkok, Thailand